Clinical Trial Update: The Efficacy and Safety of Docetaxel Combined With Platinum for Metastatic Hormone-sensitive Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the efficacy and safety of docetaxel combined with platinum in metastatic hormone-sensitive prostate cancer, including …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dna Damage Repair Deficiency
• Hormone-sensitive Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Platinum (Platinum-based chemotherapy)

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Hormone Sensitive Metastatic Prostate Cancer, DNA Damage Repair Deficiency | Phase 2 | Status: UNKNOWN